Advertisement
NEW YORK (Reuters) - Swiss pharmaceutical company Roche Holding AG will suspend its HIV research because none of its pending medicines represent significant improvement over existing drugs, a company spokeswoman said on Friday.



Discuss   Share This  Tell a friend   Discard


Comments Who Ranked Related Links